AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Dazirate-ER 500 Tablet

Prescription Icon
Prescription Required

Marketer

Unistar Biotech Ltd

Salt Composition

Divalproex (500mg)

Overview Dazirate-ER 500 Tablet

Epileptic seizures and migraine prophylaxis are key applications of the extended-release formulation of Dazirate 500mg tablets. This medication can also be prescribed for bipolar disorder management, either as monotherapy or in conjunction with other treatments. Dosage and frequency are determined individually by your physician to optimize symptom control. Consistent daily intake, regardless of meal timing, is crucial for efficacy, generally observed within a couple of weeks of initiating therapy. Continuous use, as directed, is vital; discontinuation or missed doses increase seizure risk and may exacerbate the underlying condition. Gradual tapering is essential when cessation is deemed necessary. Common side effects, often mild and transient, include headache, visual disturbances, nausea, vomiting, vertigo, fatigue, ataxia, easy bruising, and hypothermia. Persistent or bothersome effects warrant medical consultation; immediate medical attention is required for skin rashes or redness. Long-term use may result in osteoporosis, increasing fracture risk, and a small but notable increase in suicidal ideation and behavior; report any depressive symptoms promptly. Prior to commencing treatment, inform your physician of any pre-existing cardiovascular conditions, hepatic or renal impairment, urinary dysfunction, depression history, or suicidal tendencies. Drug interactions are possible; a complete medication list should be provided to ensure safety. Consult your doctor before altering medication during pregnancy. Alcohol consumption should be minimized due to increased side effect potential and seizure risk. Regular blood monitoring, both pre- and post-treatment initiation, assists in dose optimization.

Uses of Dazirate-ER 500 Tablet

Managing epileptic seizures and bipolar disorder, along with migraine prevention.

Major Benefits of Dazirate-ER 500 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Dazirate-ER 500 Tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency is key—take it at the same time each day.

Common Side effects of Dazirate-ER 500 Tablet:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Dazirate-ER 500 Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Dazirate-ER 500 Tablet should be swallowed whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for best results.

How Dazirate-ER 500 Tablet works:

Epileptic seizures are managed by Dazirate-ER 500mg tablets, an anticonvulsant that reduces hyperactive neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Dazirate-ER 500 mg tablets and alcohol can lead to significant sedation.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Dazirate-ER 500 Tablets during pregnancy poses a confirmed risk to the fetus. Prescribing it is uncommon, reserved only for life-threatening conditions where potential benefits outweigh the known dangers. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Dazirate 500mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by side effects associated with Dazirate-ER 500 Tablet.

KidneyKidneySAFE IF PRESCRIBED

Dazirate-ER 500 mg tablets pose no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverUNSAFE

The use of Dazirate-ER 500 Tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Dazirate-ER 500 Tablet :

Should you forget a Dazirate-ER 500 Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dazirate-ER 500 Tablet

LabelValue
Chemical Classification Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience (CNS)
Actions Anticonvulsant sodium channel blockers

FAQs on Dazirate-ER 500 Tablet

Always consult your doctor before discontinuing Dazirate-ER 500 Tablet. Withdrawal should be gradual and supervised to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors. Abrupt cessation is strongly discouraged.
Dazirate-ER 500 Tablets can act as a mood stabilizer in some cases, particularly for individuals experiencing rapid mood swings. Its mechanism involves reducing excessive brain activity associated with these mood changes.
Dazirate-ER 500 Tablets can cause weight gain, possibly from increased appetite. Maintain a healthy diet and exercise to minimize this risk. Consult your doctor if you have weight gain concerns.
Dazirate-ER 500 Tablets can cause drowsiness. Refrain from driving or activities requiring alertness until you understand its effects on you.
Hair loss is a possible side effect of Dazirate-ER 500 Tablets, typically temporary and related to dosage. Consult your doctor if this side effect concerns you or continues.
Dazirate-ER 500 Tablet can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are recommended before starting and periodically during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Do not drink alcohol while taking Dazirate-ER 500 Tablets. Combining alcohol with this medication can increase drowsiness, dizziness, or lightheadedness.
Prior to commencing Dazirate-ER 500 Tablet treatment, your doctor may order blood tests. These may assess blood cell counts (including platelets), bleeding time, and coagulation, helping to prevent spontaneous bleeding or bruising. Liver function tests are also recommended before, and then periodically monitored during the initial six months of treatment, especially for high-risk individuals or those with pre-existing liver conditions.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result requires immediate medication cessation.
Dazirate-ER 500 Tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and drowsiness. Muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain are also possible. Seek immediate medical help if an overdose occurs.
Dazirate-ER 500 Tablet
104
MRP 120
13% off